Proteomics reveals the effects of sustained weight loss on the human plasma proteome

Molecular Systems Biology

Volumn 12, Issue 12, 2016, Pages

  Geyer, Philipp E ^a,b   Wewer Albrechtsen, Nicolai J ^b   Tyanova, Stefka ^a   Grassl, Niklas ^a   Iepsen, Eva W ^b   Lundgren, Julie ^b   Madsbad, Sten ^b,c   Holst, Jens J ^b   Torekov, Signe S ^b   Mann, Matthias ^a,b  

^a MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c HVIDOVRE HOSPITAL   (Denmark)

Author keywords

diabetes; mass spectrometry; metabolic syndrome; obesity; plasma proteome profiling

Indexed keywords

ADIPONECTIN; ALPHA 2 MACROGLOBULIN; APOLIPOPROTEIN A1; CLUSTERIN; COMPLEMENT FACTOR H; HEMOPEXIN; KININOGEN; LIPOPROTEIN A; PLASMA PROTEIN; PREGNANCY ASSOCIATED ALPHA2 GLYCOPROTEIN; RHO GUANINE NUCLEOTIDE DISSOCIATION INHIBITOR 1; RHO GUANINE NUCLEOTIDE DISSOCIATION INHIBITOR 2; SERUM ALBUMIN; VITAMIN D BINDING PROTEIN; APOLIPOPROTEIN; EYE PROTEIN; NERVE GROWTH FACTOR; PIGMENT EPITHELIUM-DERIVED FACTOR; SERINE PROTEINASE INHIBITOR;

ADULT; AGED; ARTICLE; BODY MASS; BODY WEIGHT MAINTENANCE; FEMALE; HUMAN; INFLAMMATION; INSULIN RESISTANCE; LIFESTYLE MODIFICATION; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEOMICS; TANDEM MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; WEIGHT REDUCTION; BLOOD; BODY WEIGHT LOSS; CALORIC RESTRICTION; DIET THERAPY; GENE EXPRESSION REGULATION; LONGITUDINAL STUDY; METABOLISM; MIDDLE AGED; OBESITY; PLASMA; PROCEDURES; YOUNG ADULT;

ADULT; APOLIPOPROTEINS; CALORIC RESTRICTION; EYE PROTEINS; GENE EXPRESSION REGULATION; HUMANS; INSULIN RESISTANCE; LONGITUDINAL STUDIES; MASS SPECTROMETRY; MIDDLE AGED; NERVE GROWTH FACTORS; OBESITY; PLASMA; PROTEOMICS; SERPINS; WEIGHT LOSS; YOUNG ADULT;

EID: 85007460185     PISSN: None     EISSN: 17444292     Source Type: Journal    
DOI: 10.15252/msb.20167357     Document Type: Article

References (60)

1. Aebersold R, Mann M (2016) Mass-spectrometric exploration of proteome structure and function. Nature 537: 347–355
2. Anderson NL (2010) The clinical plasma proteome: a survey of clinical assays for proteins in plasma and serum. Clin Chem 56: 177–185
3. Anderson NL (2014) Six decades searching for meaning in the proteome. J Proteomics 107: 24–30
4. Azrad M, Gower BA, Hunter GR, Nagy TR (2012) Intra-abdominal adipose tissue is independently associated with sex-hormone binding globulin in premenopausal women. Obesity (Silver Spring) 20: 1012–1015
5. Bozaoglu K, Attard C, Kulkarni H, Cummings N, Diego VP, Carless MA, Shields KA, Johnson MP, Kowlessur S, Dyer TD, Comuzzie AG, Almasy L, Zimmet P, Moses EK, Goring HH, Curran JE, Blangero J, Jowett JB (2014) Plasma levels of soluble interleukin 1 receptor accessory protein are reduced in obesity. J Clin Endocrinol Metab 99: 3435–3443
6. Carlsson L, Lind L, Larsson A (2010) Reference values for 27 clinical chemistry tests in 70-year-old males and females. Gerontology 56: 259–265
7. Casazza K, Pate R, Allison DB (2013) Myths, presumptions, and facts about obesity. N Engl J Med 368: 2236–2237
8. Ceron JJ, Tecles F, Tvarijonaviciute A (2014) Serum paraoxonase 1 (PON1) measurement: an update. BMC Vet Res 10: 74
9. Cominetti O, Nunez Galindo A, Corthesy J, Oller Moreno S, Irincheeva I, Valsesia A, Astrup A, Saris WH, Hager J, Kussmann M, Dayon L (2016) Proteomic biomarker discovery in 1000 human plasma samples with mass spectrometry. J Proteome Res 15: 389–399
10. Cox J, Mann M (2008) MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat Biotechnol 26: 1367–1372
11. Cox J, Neuhauser N, Michalski A, Scheltema RA, Olsen JV, Mann M (2011) Andromeda: a peptide search engine integrated into the MaxQuant environment. J Proteome Res 10: 1794–1805
12. Cox J, Hein MY, Luber CA, Paron I, Nagaraj N, Mann M (2014) Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ. Mol Cell Proteomics 13: 2513–2526
13. Crawford PT, Elisens WJ (2006) Genetic variation and reproductive system among North American species of Nuttallanthus (Plantaginaceae). Am J Bot 93: 582–591
14. Dominiczak MH, Caslake MJ (2011) Apolipoproteins: metabolic role and clinical biochemistry applications. Ann Clin Biochem 48: 498–515
15. Duke-Cohan JS, Gu J, McLaughlin DF, Xu Y, Freeman GJ, Schlossman SF (1998) Attractin (DPPT-L), a member of the CUB family of cell adhesion and guidance proteins, is secreted by activated human T lymphocytes and modulates immune cell interactions. Proc Natl Acad Sci USA 95: 11336–11341
16. Eckel RH, Grundy SM, Zimmet PZ (2005) The metabolic syndrome. Lancet 365: 1415–1428
17. Esser N, Legrand-Poels S, Piette J, Scheen AJ, Paquot N (2014) Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Res Clin Pract 105: 141–150
18. Famulla S, Lamers D, Hartwig S, Passlack W, Horrighs A, Cramer A, Lehr S, Sell H, Eckel J (2011) Pigment epithelium-derived factor (PEDF) is one of the most abundant proteins secreted by human adipocytes and induces insulin resistance and inflammatory signaling in muscle and fat cells. Int J Obes (Lond) 35: 762–772
19. Geyer PE, Kulak NA, Pichler G, Holdt LM, Teupser D, Mann M (2016) Plasma proteome profiling to assess human health and disease. Cell Syst 2: 185–195
20. Goodpaster BH, Delany JP, Otto AD, Kuller L, Vockley J, South-Paul JE, Thomas SB, Brown J, McTigue K, Hames KC, Lang W, Jakicic JM (2010) Effects of diet and physical activity interventions on weight loss and cardiometabolic risk factors in severely obese adults: a randomized trial. JAMA 304: 1795–1802
21. van Greevenbroek MM, Schalkwijk CG, Stehouwer CD (2013) Obesity-associated low-grade inflammation in type 2 diabetes mellitus: causes and consequences. Neth J Med 71: 174–187
22. Grundy SM (2015) Adipose tissue and metabolic syndrome: too much, too little or neither. Eur J Clin Invest 45: 1209–1217
23. Hansen BA, Bray GA (2008) The metabolic syndrome: epidemiology, clinical treatment, and underlying mechanisms. Totowa, NJ: Humana Press
24. Hirai K, Hussey HJ, Barber MD, Price SA, Tisdale MJ (1998) Biological evaluation of a lipid-mobilizing factor isolated from the urine of cancer patients. Cancer Res 58: 2359–2365
25. Iepsen EW, Lundgren J, Dirksen C, Jensen JE, Pedersen O, Hansen T, Madsbad S, Holst JJ, Torekov SS (2015) Treatment with a GLP-1 receptor agonist diminishes the decrease in free plasma leptin during maintenance of weight loss. Int J Obes (Lond) 39: 834–841
26. Kamstrup PR, Benn M, Tybjaerg-Hansen A, Nordestgaard BG (2008) Extreme lipoprotein(a) levels and risk of myocardial infarction in the general population: the Copenhagen City Heart Study. Circulation 117: 176–184
27. Kulak NA, Pichler G, Paron I, Nagaraj N, Mann M (2014) Minimal, encapsulated proteomic-sample processing applied to copy-number estimation in eukaryotic cells. Nat Methods 11: 319–324
28. Kushner RF, Ryan DH (2014) Assessment and lifestyle management of patients with obesity: clinical recommendations from systematic reviews. JAMA 312: 943–952
29. Laudes M, Oberhauser F, Schulte DM, Schilbach K, Freude S, Bilkovski R, Schulz O, Faust M, Krone W (2010) Dipeptidyl-peptidase 4 and attractin expression is increased in circulating blood monocytes of obese human subjects. Exp Clin Endocrinol Diabetes 118: 473–477
30. Laugerette F, Alligier M, Bastard JP, Drai J, Chanseaume E, Lambert-Porcheron S, Laville M, Morio B, Vidal H, Michalski MC (2014) Overfeeding increases postprandial endotoxemia in men: inflammatory outcome may depend on LPS transporters LBP and sCD14. Mol Nutr Food Res 58: 1513–1518
31. Lewis JG, Bagley CJ, Elder PA, Bachmann AW, Torpy DJ (2005) Plasma free cortisol fraction reflects levels of functioning corticosteroid-binding globulin. Clin Chim Acta 359: 189–194
32. Li XA, Yutani C, Shimokado K (1998) Serum amyloid P component associates with high density lipoprotein as well as very low density lipoprotein but not with low density lipoprotein. Biochem Biophys Res Commun 244: 249–252
33. Liu Y, Buil A, Collins BC, Gillet LC, Blum LC, Cheng LY, Vitek O, Mouritsen J, Lachance G, Spector TD, Dermitzakis ET, Aebersold R (2015) Quantitative variability of 342 plasma proteins in a human twin population. Mol Syst Biol 11: 786
34. Look ARG, Wing RR, Bolin P, Brancati FL, Bray GA, Clark JM, Coday M, Crow RS, Curtis JM, Egan CM, Espeland MA, Evans M, Foreyt JP, Ghazarian S, Gregg EW, Harrison B, Hazuda HP, Hill JO, Horton ES, Hubbard VS et al (2013) Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med 369: 145–154
35. Malmstrom E, Kilsgard O, Hauri S, Smeds E, Herwald H, Malmstrom L, Malmstrom J (2016) Large-scale inference of protein tissue origin in gram-positive sepsis plasma using quantitative targeted proteomics. Nat Commun 7: 10261
36. Mann M, Kulak NA, Nagaraj N, Cox J (2013) The coming age of complete, accurate, and ubiquitous proteomes. Mol Cell 49: 583–590
37. McEneny J, Daniels JA, McGowan A, Gunness A, Moore K, Stevenson M, Young IS, Gibney J (2015) A cross-sectional study demonstrating increased serum amyloid a related inflammation in high-density lipoproteins from subjects with type 1 diabetes mellitus and how this association was augmented by poor Glycaemic control. J Diabetes Res 2015: 351601
38. Munoz J, Heck AJ (2014) From the human genome to the human proteome. Angew Chem 53: 10864–10866
39. Nagaraj N, Kulak NA, Cox J, Neuhauser N, Mayr K, Hoerning O, Vorm O, Mann M (2012) System-wide perturbation analysis with nearly complete coverage of the yeast proteome by single-shot ultra HPLC runs on a bench top Orbitrap. Mol Cell Proteomics 11: M111.013722
40. Newgard CB (2016) Metabolomics and metabolic diseases: where do we stand? Cell Metab doi: 10.1016/j.cmet.2016.09.018
41. Pellet-Many C, Frankel P, Jia H, Zachary I (2008) Neuropilins: structure, function and role in disease. Biochem J 411: 211–226
42. Piccolo BD, Keim NL, Fiehn O, Adams SH, Van Loan MD, Newman JW (2015) Habitual physical activity and plasma metabolomic patterns distinguish individuals with low vs. high weight loss during controlled energy restriction. J Nutr 145: 681–690
43. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR (2002) Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 347: 1557–1565
44. Riecke BF, Christensen R, Christensen P, Leeds AR, Boesen M, Lohmander LS, Astrup A, Bliddal H (2010) Comparing two low-energy diets for the treatment of knee osteoarthritis symptoms in obese patients: a pragmatic randomized clinical trial. Osteoarthritis Cartilage 18: 746–754
45. Scheltema RA, Mann M (2012) SprayQc: a real-time LC-MS/MS quality monitoring system to maximize uptime using off the shelf components. J Proteome Res 11: 3458–3466
46. Scheltema RA, Hauschild JP, Lange O, Hornburg D, Denisov E, Damoc E, Kuehn A, Makarov A, Mann M (2014) The Q Exactive HF, a Benchtop mass spectrometer with a pre-filter, high-performance quadrupole and an ultra-high-field Orbitrap analyzer. Mol Cell Proteomics 13: 3698–3708
47. Selvin E, Paynter NP, Erlinger TP (2007) The effect of weight loss on C-reactive protein: a systematic review. Arch Intern Med 167: 31–39
48. Seres I, Bajnok L, Harangi M, Sztanek F, Koncsos P, Paragh G (2010) Alteration of PON1 activity in adult and childhood obesity and its relation to adipokine levels. Adv Exp Med Biol 660: 129–142
49. Smith DE, Hanna R, Della F, Moore H, Chen H, Farese AM, MacVittie TJ, Virca GD, Sims JE (2003) The soluble form of IL-1 receptor accessory protein enhances the ability of soluble type II IL-1 receptor to inhibit IL-1 action. Immunity 18: 87–96
50. Soker S, Takashima S, Miao HQ, Neufeld G, Klagsbrun M (1998) Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 92: 735–745
51. Surinova S, Schiess R, Huttenhain R, Cerciello F, Wollscheid B, Aebersold R (2011) On the development of plasma protein biomarkers. J Proteome Res 10: 5–16
52. Thompson PA, Tobias PS, Viriyakosol S, Kirkland TN, Kitchens RL (2003) Lipopolysaccharide (LPS)-binding protein inhibits responses to cell-bound LPS. J Biol Chem 278: 28367–28371
53. Tyanova S, Temu T, Sinitcyn P, Carlson A, Hein M, Geiger T, Mann M, Cox J (2016) The Perseus computational platform for comprehensive analysis of (prote)omics data. Nat Methods 13: 731–740
54. Utermann G (1989) The mysteries of lipoprotein(a). Science 246: 904–910
55. Wahl S, Vogt S, Stuckler F, Krumsiek J, Bartel J, Kacprowski T, Schramm K, Carstensen M, Rathmann W, Roden M, Jourdan C, Kangas AJ, Soininen P, Ala-Korpela M, Nothlings U, Boeing H, Theis FJ, Meisinger C, Waldenberger M, Suhre K et al (2015) Multi-omic signature of body weight change: results from a population-based cohort study. BMC Med 13: 48
56. Wang P, Mariman E, Keijer J, Bouwman F, Noben JP, Robben J, Renes J (2004) Profiling of the secreted proteins during 3T3-L1 adipocyte differentiation leads to the identification of novel adipokines. Cell Mol Life Sci 61: 2405–2417
57. Wang P, Smit E, Brouwers MC, Goossens GH, van der Kallen CJ, van Greevenbroek MM, Mariman EC (2008) Plasma pigment epithelium-derived factor is positively associated with obesity in Caucasian subjects, in particular with the visceral fat depot. Eur J Endocrinol 159: 713–718
58. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA (2001) Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86: 1930–1935
59. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW (1999) C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 19: 972–978
60. Zubarev RA, Makarov A (2013) Orbitrap mass spectrometry. Anal Chem 85: 5288–5296